Scientific Program
Time | Topic | Speaker |
---|---|---|
Day 1 April 20th | Morning Session | Session Chair: Sharon Nofech-Mozes |
11:00 | Welcome | CBQA |
11:15 | Keynote lecture: Overview of Breast Cancer Biomarker Testing | Kimberley Allison, Stanford University, Stanford CA USA |
12:00 | Laboratory Accreditation in Canada | Jennifer Roberts, Accreditation Canada, Ottawa, Canada |
12:30 | QuPath, an open-source Software for Bio-image Analysis: installation and practical example demonstrating Ki67 percentage calculation from IHC assays whole slide images | Gilbert Bigras, Alberta Health Services, Edmonton, Canada |
1:00 - 1:45 | Break | |
Day 1 April 20th | Afternoon Session | Session Chair: Tracy Stockley |
1:45 | Clinical Laboratory Implementation of Optical Genome Mapping | Adam Smith, University Health Network, Toronto, Canada |
2:15 | Applications of Image Analysis to PD-L1 Combined Positive Score (CPS) Readout | Pierre Fiset, McGill University, Montreal, Canada |
2:45 | Quality Assurance for Clinical Whole Genome Sequencing | Christian Marshall, The Hospital for Sick Children, Toronto |
3:15 | Closing remarks | CBQA |
Time | Topic | Speaker |
Day 2 April 21st | Morning Session | Session Chair: Tracy Stockley |
11:00 | Welcome | CBQA |
11:15 | Keynote Lecture: Overview of the European Molecular Quality Network (EMQN) | Simon Paton, EMQN, Manchester, UK |
12:00 | Immunohistochemistry; The NordiQC Experience | Søren Nielsen, NordiQC, Aalborg, Denmark |
12:30 | Harmonization of Ki67 Analytical Performance | Megan Troxell, Stanford University, Stanford, CA USA |
1:00 - 1:45 | Break | |
Day 2 April 21st | Afternoon Session | Session Chair: Sharon Nofech-Mozes |
1:45 | Repurposing Biomarker Assays (general concepts) | Emina Torlakovic, University of Saskatchewan, Saskatoon, Canada |
2:15 | Immunohistochemistry for Ki67 in Breast Cancer | Allen Gown, University of British Columbia, Vancouver, Canada |
2:45 | HER2 Immunohistochemistry in Breast Cancer | Sharon Nofech-Mozes Sunnybrook Health Sciences Centre, Toronto, Canada |
3:15 | Closing remarks | CBQA |